Juncos, Jorge L.

Reliability of a new scale for essential tremor

Elble, R., Comella, C., Fahn, S., Hallett, M., Jankovic, J., Juncos, J. L., LeWitt, P., Lyons, K., Ondo, W., Pahwa, R., et al. (2012) · Movement Disorders

Neurological disorders and treatmentsMotor Control and Adaptation

Cited by 244

Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases

Coppola, G., Chinnathambi, S., Lee, J. J., Dombroski, B. A., Baker, M. C., Soto-Ortolaza, A. I., Lee, S. E., Klein, E., Huang, A. Y., Sears, R., et al. (2012) · Human Molecular Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 240

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

Kouri, N., Ross, O. A., Dombroski, B., Younkin, C. S., Serie, D. J., Soto-Ortolaza, A., Baker, M., Finch, N. C. A., Yoon, H., Kim, J., et al. (2015) · Nature Communications

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Cited by 219

Benefits and Risks of Pharmacological Treatments for Essential Tremor

Lyons, K. E., Pahwa, R., Comella, C. L., Eisa, M. S., Elble, R. J., Fahn, S., Jankovic, J., Juncos, J. L., Koller, W. C., Ondo, W. G., et al. (2003) · Drug Safety

Neurological disorders and treatmentsBotulinum Toxin and Related Neurological Disorders

Cited by 103

Parkinson's and Alzheimer's diseases in Costa Rica: a feasibility study toward a national screening program

Wesseling, C., Román, N., Quirós, I., Páez, L., García, V., María Mora, A., Juncos, J. L., & Steenland, K. N. (2013) · Global Health Action

Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments

Cited by 9